Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413296 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mugdha V Patwardhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tumor Microenvironment, Immunotherapy, BCG Vaccine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joseph Lim Boon Tiong Cancer Research Initiative, Joseph Lim Boon Tiong Urology Cancer Research Initiative.
Abstract (Originalsprache)
Loss of the glutathione-S-transferases Theta 2 (Gstt2) expression is associated with an improved response to intravesical Mycobacterium bovis, Bacillus Calmette-Guérin (BCG) immunotherapy for non-muscle-invasive bladder cancer (NMIBC) patients who receive fewer BCG instillations. To delineate the cause, Gstt2 knockout (KO) and wildtype (WT) C57Bl/6J mice were implanted with tumors before treatment with BCG or saline. RNA was analyzed via single-cell RNA sequencing (scRNA-seq) and real-time polymerase chain reaction (RT-PCR). BCG induced PD-L1 expression in WT mice bladders, while pro-inflammatory TNF-α was upregulated in KO bladders. ScRNA-seq analysis showed that Gstt2 WT mice bladders had a higher proportion of matrix remodeling fibroblasts, M2 macrophages, and neuronal cells. In KO mice, distinct tumor cell types, activated fibroblasts, and M1 macrophages were enriched in the bladders. In WT bladders, the genes expressed supported tumorigenesis and immunosuppressive PD-L1 expression. In contrast, Gstt2 KO bladders expressed genes involved in inflammation, immune activation, and tumor suppression. An 11-gene signature (Hmga2, Peak 1, Kras, Slc2a1, Ankfn1, Ahnak, Cmss1, Fmo5, Gphn, Plec, Gstt2), derived from the scRNA-seq analysis predicted response in NMIBC patients (The Cancer Genome Atlas (TCGA) database). In conclusion, our results indicate that patients with WT Gstt2 may benefit from anti-PD-L1 checkpoint inhibition therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
- Genomics and Data Analytics Core, Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
- Department of Urology, National University Hospital, National University Health System, Singapore 119074, Singapore.
ORCID-Profile: Mugdha V Patwardhan, Toh Qin Kane, Juwita Norasmara Rahmat, Ratha Mahendran
Förderung
- Joseph Lim Boon Tiong Cancer Research Initiative
- Joseph Lim Boon Tiong Urology Cancer Research Initiative
Zitieren
APA
Patwardhan, M. V., Kane, T. Q., Chiong, E., Rahmat, J. N., & Mahendran, R. (2024). Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413296
Vancouver
Patwardhan MV, Kane TQ, Chiong E, Rahmat JN, Mahendran R. Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413296
BibTeX
@article{Patwardhan2024,
author = {Patwardhan, Mugdha V and Kane, Toh Qin and Chiong, Edmund and Rahmat, Juwita Norasmara and Mahendran, Ratha},
title = {Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413296}
}
EUVIMED